New approach could expand CAR T therapy from blood cancers to solid tumors, Pitt–NCI study finds
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Oct-2026 12:17 ET (26-Oct-2026 16:17 GMT/UTC)
Researchers at the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute report that combining CAR T cell immunotherapy with a targeted radiopharmaceutical significantly improved tumor regression in preclinical models of neuroblastoma, a rare and aggressive cancer that usually forms in nerve tissue outside the brain that primarily affects children. The findings were published in Cell Reports Medicine.
A study examining air quality and respiratory health in communities surrounding the Salton Sea in Southern California shows how environmental conditions, poor housing quality, and structural inequities combine to place children at greater risk for respiratory illness.